Mid-Cap Exodus: A Portfolio’s Quiet Turn

In the dry light of an SEC filing, the reduction of FNX exposure became a story of arithmetic and restraint. The shares, once a modest 1.47% of the firm’s reportable assets, now sit as a shadow in the portfolio’s broader tapestry. The numbers-47,314 shares, $5.92 million-feel clinical, but the act itself is human: a portfolio manager adjusting a collar in a storm, not out of panic, but to keep the coat from flapping loose.



